Last updated on July 2019

An Investigational Immuno-therapy Study of Nivolumab or Placebo in Patients With Resected Esophageal or Gastroesophageal Junction Cancer


Brief description of study

The purpose of this study is to determine whether Nivolumab will improve overall survival, disease-free survival, or both compared with placebo.

Clinical Study Identifier: NCT02743494

Find a site near you

Start Over

Ucsf Cancer Center

San Francisco, CA United States
  Connect »

University Of Colorado

Aurora, CO United States
  Connect »

Florida Cancer Specialists

Fort Myers, FL United States
  Connect »

Cancer Specialists of North FL

Jacksonville, FL United States
  Connect »

Sacred Heart Medical Group

Pensacola, FL United States
  Connect »

SCRI Florida Cancer Specialists North

Saint Petersburg, FL United States
  Connect »

University Of Chicago

Chicago, IL United States
  Connect »

NYU Langone Medical Center

New York, NY United States
  Connect »

Levine Cancer Institute

Charlotte, NC United States
  Connect »

Duke Cancer Center

Durham, NC United States
  Connect »

Local Institution

Oklahoma City, OK United States
  Connect »

Oregon Health & Sci Univ

Portland, OR United States
  Connect »

Lehigh Valley Hospital

Allentown, PA United States
  Connect »

Fox Chase Cancer Center

Philadelphia, PA United States
  Connect »

Allegheny Health Network

Pittsburgh, PA United States
  Connect »

Vanderbilt University Med Ctr

Nashville, TN United States
  Connect »

Dallas VA Medical Center

Dallas, TX United States
  Connect »

University of Washington

Seattle, WA United States
  Connect »

University Of Wisconsin

Madison, WI United States
  Connect »

Fundacion Favaloro

Buenos Aires, Argentina
  Connect »

Hospital Britanico

Buenos Aires, Argentina
  Connect »

Local Institution

Blacktown, Australia
  Connect »

Local Institution

Tamworth, Australia
  Connect »

Local Institution

Trois-Rivieres, QC Canada
  Connect »

Local Institution

Avignon Cedes 9, France
  Connect »

Local Institution

Dijon Cedex, France
  Connect »

Local Institution

LILLE Cedex, France
  Connect »

Local Institution

Pierre Benite Cedex, France
  Connect »

Local Institution

Rennes Cedex 9, France
  Connect »

Local Institution

Petach Tikva, Israel
  Connect »

Local Institution

Hiroshima-Shi, Japan
  Connect »

Local Institution

Kagoshima-shi, Japan
  Connect »

Local Institution

Kumamoto-shi, Japan
  Connect »

Local Institution

Osaka-sayama-shi, Japan
  Connect »

Local Institution

Kitaadachi-gun, Japan
  Connect »

Local Institution

Shinjuuku-ku, Japan
  Connect »

Local Institution

Seoul, Korea, Republic of
  Connect »

Local Institution

Amsterdam, Netherlands
  Connect »

Local Institution

Groningen, Netherlands
  Connect »

Local Institution

Maastrict, Netherlands
  Connect »

Local Institution

San Juan, Puerto Rico
  Connect »

Bendis Clinic Srl

Cluj-Napoca, Romania
  Connect »

Local Institution

Cheboksary, Russian Federation
  Connect »

Local Institution

Moscow, Russian Federation
  Connect »

Local Institution

St. Petersburg, Russian Federation
  Connect »

Local Institution

Singapore, Singapore
  Connect »

Local Institution

London, United Kingdom
  Connect »

Local Institution

Southampton, United Kingdom
  Connect »

Local Institution

Withington, United Kingdom
  Connect »

Local Institution

Sutton, United Kingdom
  Connect »

Georgetown University Med Ctr

Washington, WA United States
  Connect »

Local Institution

Brisbane, Australia
  Connect »

Bendis Clinic Srl

Cluj-napoca, Romania
  Connect »

Local Institution

Hong Kong, Hong Kong
  Connect »

Local Institution

Cardiff, United Kingdom
  Connect »

Local Institution

Fargo, ND United States
  Connect »

Local Institution

Sioux Falls, SD United States
  Connect »

Local Institution

Dallas, TX United States
  Connect »

Local Institution

Phoenix, AZ United States
  Connect »

Local Institution

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.